Quantcast
Last updated on April 16, 2014 at 1:21 EDT

Latest TB Stories

2012-10-23 20:48:07

A study led by The University of Manchester has demonstrated that new technology that can analyze millions of gene sequences in a matter of seconds is an effective way to quickly and accurately identify diseases in skeletons. Professor Terry Brown, working in partnership with Professor Charlotte Roberts from Durham University, used a next generation sequencing approach, including hybridization capture technology, to identify tuberculosis genes in a 19th century female skeleton found in a...

2012-10-09 23:20:19

Phase IIb Proof of Concept Trial Planned for Kenya, India and South Africa ROCKVILLE, Md., Oct. 10, 2012 /PRNewswire-USNewswire/ -- Aeras announces that it has signed an agreement with GlaxoSmithKline Vaccines, S.A. (GSK) to jointly advance the clinical development of an investigational tuberculosis (TB) vaccine containing GSK's proprietary M72 antigen and AS01(E)(*) adjuvant. This novel research and resource-sharing agreement between the largest non-profit TB vaccine biotech and one...

2012-09-27 10:10:56

Results from an observational study evaluating a new anti-TB drug have found that the treatment can improve outcomes and reduce mortality among patients with both MDR-TB and XDR-TB. The research, published online ahead of print today (27 September 2012) in the European Respiratory Journal, suggests a drug called delamanid could have a public health benefit for MDR-TB and also for XDR-TB, as few effective treatment options are currently available. Over the past two decades,...

2012-09-20 02:28:47

PARIS and NEW YORK, Sept. 20, 2012 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and the Global Alliance for TB Drug Development (TB Alliance) announced today a new research collaboration agreement to accelerate the discovery and development of novel compounds against tuberculosis (TB), a deadly infectious disease that resulted in almost 1.5 million deaths worldwide(1) in 2010. (Logo: http://photos.prnewswire.com/prnh/20110616/NY20158LOGO ) Under the agreement, Sanofi and...

Drug-resistant Tuberculosis Killed By Old Pain Drug
2012-09-11 09:08:37

April Flowers for redOrbit.com - Your Universe Online Researchers at Weill Cornell Medical College have found that an off-patent anti-inflammatory drug that costs about two cents for a daily dose can also kill both replicating and non-replicating drug-resistant tuberculosis in the laboratory. Few currently approved TB drugs can do this, and resistance to those is spreading. Reported in the Proceedings of the National Academy of Sciences, the study points to a potential new therapy for...

2012-09-10 23:04:28

Critical Path Institute and CDISC (Clinical Data Interchange Standards Consortium) announce the availability of a breakthrough tool to help combat tuberculosis (TB)–a persistent disease resulting in 1.7 million deaths globally each year. Tucson, AZ (PRWEB) September 10, 2012 Critical Path Institute and CDISC (Clinical Data Interchange Standards Consortium) announce the availability of a breakthrough tool to help combat tuberculosis (TB)–a persistent disease resulting in 1.7...

2012-09-04 11:25:20

Reconstructing the spread of killer diseases such as tuberculosis (TB) from person to person using DNA sequencing quickly identifies the origin and movement of pathogens. This approach is directly informing public health strategies to control infectious disease outbreaks, says a scientist speaking at the Society for General Microbiology's Autumn Conference at the University of Warwick. A team from the British Columbia Centre for Disease Control in Vancouver, Canada used whole-genome...

Tuberculosis Patients Have Speedy Recovery With Antibiotics And Vitamin D
2012-09-04 09:45:27

Lawrence LeBlond for redOrbit.com - Your Universe Online Recent studies have shown that vitamin D deficiencies can make people gain weight and also worsen lung function in smokers. And other research has shown that vitamin D intake can reduce the risk of respiratory infection in children. Now, researchers from Queen Mary University of London have found that the “sunshine” vitamin can also aid in a speedy recovery from tuberculosis (TB). According to researchers involved in...

2012-08-30 22:20:50

BEERSE, Belgium, August 31, 2012 /PRNewswire/ -- Janssen-Cilag International NV (Janssen) today announced it has submitted a Marketing Authorisation Application to the European Medicines Agency (EMA) seeking conditional approval for the use of the investigational drug bedaquiline (TMC207) as an oral treatment, to be used as part of combination therapy for pulmonary, multi-drug resistant tuberculosis (MDR-TB) in adults. If approved, bedaquiline (Ba-DA-qui-lin) could be one of the...

2012-08-24 23:03:37

Global NGO's Program to Improve Health of Ukrainians Through TB Testing And Other Measures to Prevent Rapid Increase of the Disease in Ukraine - Fifth Largest TB Burden Country In the World. Millwood, VA (PRWEB) August 23, 2012 Project HOPE, a global health education and humanitarian assistance organization, has received $4.7 million from USAID to strengthen the tuberculosis (TB) infection control program in Ukraine. The five-year program will be implemented with Chemonics. The program...